Johnson & Johnson
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.JNJ News
A bottle of Johnson and Johnson's baby powder is seen in a photo illustration taken in New York, February 24, 2016. REUTERS/Mike Segar/Illustration/File Photo A...
Tuesday, December 5, 2023 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research report...
Loading... Loading... Loading... Johnson & Johnson JNJ expects operational sales growth in the range of 5%-6% for FY24. The company forecasts adjusted operati...
Analyst ratings
57%
of 23 ratingsMore JNJ News
(Adds analyst comments in paragraphs 3, 7 and 9) By Patrick Wingrove and Bhanvi Satija Dec 5 (Reuters) - Johnson & Johnson on Tuesday forecast revenue growth...
Shares of healthcare major Johnson & Johnson (NYSE:JNJ) are in focus today after the company announced key long-term goals and financial outlook on the sideline...
Check out the companies making headlines before the bell. GitLab — GitLab shares popped more than 14% after the maker of developer tool software posted stronger...
Johnson & Johnson stock was edging higher after the pharmaceutical and medical-device company shared its long-term financial outlook. In a release before a meet...
Johnson & Johnson said its MedTech operations aim to build its position with continued expansion into high-growth markets Photo: mark ralston/Agence France-Pres...
Johnson & Johnson JNJ announced that the FDA has granted Breakthrough Therapy Designation (BTD) to its pipeline candidate, TAR-200, for the treatment of high-ri...
Johnson & Johnson expects its pharmaceuticals division will bring to market 20 new therapies for cancer, immune and neurological diseases by 2030, an outlook th...
